Industry
Altoida
Total Trials
3
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed trials have results
Key Signals
1 with results
Enrollment Performance
Analytics
N/A
1(100.0%)
1Total
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT05153941Active Not Recruiting
Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures
Role: lead
NCT06223438Completed
Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers.
Role: lead
NCT02843529Not ApplicableCompleted
Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)
Role: lead
All 3 trials loaded